Purchase Order 36C24519P0076
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $197,773.10 contract is for the procurement of CEPHEID MRSA KITS, which are molecular tests used to detect methicillin-resistant Staphylococcus aureus (MRSA) infections. The contract was awarded under Cepheid's existing General Services Administration (GSA) Federal Supply Schedule 65-VII contract for In Vitro...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions and testing products. The $198,055.70 firm fixed price contract is for the provision of Cepheid's MSRA (Methicillin-Resistant Staphylococcus Aureus) test kits. The contract has a completion date of September 30, 2020 and was awarded on October 1, 2019 without any set-aside designation. Cepheid, a subsidiary of the...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a purchase order to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide MRSA reagents. The firm-fixed-price contract, valued at $139,486.20, was awarded on October 1, 2019 and has a completion date of September 30, 2020. This contract supports the VA's clinical diagnostic programs and does not have a set-aside designation. Cepheid, a subsidiary of Danaher Corporation, is a major supplier...
- This is a firm fixed-price delivery order awarded to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Department of Veterans Affairs (VA) Veterans Health Administration. The contract is for the provision of MRSA (methicillin-resistant Staphylococcus aureus) testing products and services, including reagents, test kits, instruments, and testing platforms. The contract does not have a set-aside designation. The potential value of the award is $262,241.93, with a...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $104,930.64 contract is for the delivery of MRSA, C-DIFF, and XPRSFLU test kits to support the VA's clinical diagnostic programs. The contract does not have a set-aside designation. Cepheid is the prime contractor and sole provider for this award. As the original equipment manufacturer of the...
- This is a federal contract award from the Department of Veterans Affairs (VA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for the delivery of MRSA (Methicillin-Resistant Staphylococcus Aureus) test kits, with a ceiling value of $94,394.10. The contract is a Delivery Order under Cepheid's General Services Administration (GSA) Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Tests. This contract does not have a set-aside...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a purchase order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide 60 MRSA (Methicillin-resistant Staphylococcus aureus) test kits. The $320,904 firm fixed price contract was awarded on October 1, 2018, with a completion date of September 30, 2019. Cepheid is the sole authorized distributor for these patented MRSA testing kits. The contract also includes service for the...
- The Department of Veterans Affairs (VA) awarded a $70,467.00 firm-fixed-price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract is for MRSA CPRR testing and services, with a performance period through September 30, 2024. Cepheid is the prime contractor and original equipment manufacturer, providing diagnostic testing equipment, reagents, consumables, and associated...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostics solutions, to provide cost per test services for MRSA nasal, MRSA blood, influenza, C. diff, GC/NG, and other infectious disease tests. The $398,339.20 contract has an August 2019 completion date and was not set aside. Cepheid, a subsidiary of Danaher Corporation, provides reagents, test kits, instruments, and...
- This is a $362,738.22 firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for MRSA CPRR testing and services, with a period of performance through September 30, 2024. Cepheid, the prime contractor, is a leading provider of molecular diagnostics equipment, reagents, and support services to federal agencies, including the VA and Department of Defense. This order is...
This is a firm-fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including infectious disease test kits. The $138,177.54 contract is for the supply of MRSA (methicillin-resistant Staphylococcus aureus) and flu test kits. The contract does not utilize a set-aside designation. Cepheid has provided diagnostic testing products and services to support clinical programs at the VA, the Defense Logistics Agency, and the Department of Health and Human Services Indian Health Service. The company also holds indefinite delivery contracts with the VA and Department of the Army Medical Command for COVID-19 and influenza PCR testing, as well as an IDIQ to supply molecular reagents for its GeneXpert equipment to VA hospitals in Florida through 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $13.0k | 3/7/19 | |
| Not listed | Not listed | $125.2k | 10/9/18 |